Probiotics in the treatment of recurrent vaginal infections: Mechanisms, formulation approaches, and clinical evidence

Recurrent vaginal infections, particularly recurrent vulvovaginal candidiasis (RVVC) and bacterial vaginosis (BV), remain difficult to manage because symptom resolution does not always translate into durable restoration of the vaginal microbial ecosystem. Conventional antifungal and antibacterial agents are important for treating confirmed infections, but recurrence, antimicrobial resistance, biofilm persistence and disruption of beneficial microorganisms limit long-term outcomes. Probiotics, especially selected Lactobacillus strains, have therefore been investigated as adjunctive approaches to support vaginal microbial balance. Their proposed actions include lactic acid production, competitive exclusion of pathogens, secretion of antimicrobial substances and modulation of mucosal immune responses. This review discusses the vaginal microbiota, probiotic selection, mechanisms of action, oral and intravaginal delivery, formulation approaches, combination strategies, clinical evidence, safety and quality requirements. Particular attention is given to mucoadhesive gels and bio-gels as potential localized delivery systems. Available evidence is promising but heterogeneous, and probiotic effects are strain- and formulation-specific. Probiotics should not replace diagnostic evaluation or established antimicrobial treatment when indicated. Well-designed clinical trials and standardized pharmaceutical quality controls are required before their role in recurrent vaginal infections can be defined with greater certainty.

Authors

Publication Details

Journal
African Journal of Medicine and Pharma Research
Published
2026-11-13
DOI
https://doi.org/10.18231/j.ajmpr.87862.1794560285
Primary Topic
Reproductive tract infections research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Probiotics in the treatment of recurrent vaginal infections: Mechanisms, formulation approaches, and clinical evidence

Amol Ramesh Lahane, Nandu Rangnath Kayande, Aniket R Bhutkar
2 links
African Journal of Medicine and Pharma Research
Reproductive tract infections research
article

Probiotics in the treatment of recurrent vaginal infections: Mechanisms, formulation approaches, and clinical evidence

Amol Ramesh Lahane, Nandu Rangnath Kayande, Aniket R Bhutkar
article en

Abstract

Recurrent vaginal infections, particularly recurrent vulvovaginal candidiasis (RVVC) and bacterial vaginosis (BV), remain difficult to manage because symptom resolution does not always translate into durable restoration of the vaginal microbial ecosystem. Conventional antifungal and antibacterial agents are important for treating confirmed infections, but recurrence, antimicrobial resistance, biofilm persistence and disruption of beneficial microorganisms limit long-term outcomes. Probiotics, especially selected Lactobacillus strains, have therefore been investigated as adjunctive approaches to support vaginal microbial balance. Their proposed actions include lactic acid production, competitive exclusion of pathogens, secretion of antimicrobial substances and modulation of mucosal immune responses. This review discusses the vaginal microbiota, probiotic selection, mechanisms of action, oral and intravaginal delivery, formulation approaches, combination strategies, clinical evidence, safety and quality requirements. Particular attention is given to mucoadhesive gels and bio-gels as potential localized delivery systems. Available evidence is promising but heterogeneous, and probiotic effects are strain- and formulation-specific. Probiotics should not replace diagnostic evaluation or established antimicrobial treatment when indicated. Well-designed clinical trials and standardized pharmaceutical quality controls are required before their role in recurrent vaginal infections can be defined with greater certainty.

African Journal of Medicine and Pharma ResearchVol. 4(2)
Good health and well-being
Reproductive tract infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon